Skip to content

The impact of opioid-free anesthesia on the quality of early recovery following gynecological laparoscopic procedures

The impact of opioid-free anesthesia on the quality of early recovery following gynecological laparoscopic procedures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097828
Enrollment
Unknown
Registered
2025-02-26
Start date
2024-07-12
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoma of uteerus

Interventions

Experimental group
In the experimental cohort, a combination of lumbar anesthesia and non-opioid general analgesia was administered.:Experimental group: single lumbar anesthesia + intravenous infusion of midazolam 0.02-
Control group: intravenous infusion of midazolam 0.02-0.05mg/kg, Sufentanil 0.3µg/kg, propofol 2.0mg/kg, rocuronium 0.6mg/kg in fractional doses as needed, and sevoflurane inhalation anesthesia.
Control group: Opioid general analgesia:propofol 4-12mg/(kg· h), dexmedetomidine 0.2-0.7ug/(kg· h), rocuronium 0.15mg/kg in fractional doses as needed, and sevoflurane inhalation anesthesia.

Sponsors

Huaihe Hospital, Henan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.For patients who consented to undergo elective gynecological laparoscopic total hysterectomy, the projected duration of the procedure was anticipated to be less than two hours. 2.The subjects were within the age range of 18 to 65 years, classified with ASA physical status I or II. 3.They had no known contraindications to the administration of intraspinal anesthesia. 4 were devoid of mental abnormalities that would preclude their ability to cooperate.

Exclusion criteria

Exclusion criteria: 1.The contraindications of intraspinal anesthesia include 2.Individuals with speech communication disorders who are unable to cooperate 3.Those with a history of opioid allergy or prolonged use of opioid analgesics 4.Individuals with a history of drug use 5.Patients with coagulation dysfunction 6.Body mass index>=30kg/m2

Design outcomes

Primary

MeasureTime frame
Quality of recovery one day after surgery;

Secondary

MeasureTime frame
Arterial mean pressure at every time interval throughout the anesthetic period.;Patient demographic information;Surgery time;Anesthesia time;Extubation time;Sevoflurane consumption;Total hospital stay;Postoperative hospital stay;Time of first landing after surgery;Time of drainage tube removal;Time of anal exhaust;Total hospitalization expenses;Patient satisfaction;Preoperative one-day white blood cell (WBC) count;Postoperative one-day C-reactive protein (CRP) and WBC count;Pain;Adverse reactions;Cardiac rhythm measurements were recorded at each interval throughout the anesthetic period.;

Countries

China

Contacts

Public ContactXin Wenqi

Huaihe Hospital of Henan University

xwq_mzk@163.com+86 166 0378 1303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026